Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Infections | 18 | 2024 | 376 | 5.690 |
Why?
|
| Papillomavirus Vaccines | 10 | 2024 | 174 | 4.320 |
Why?
|
| Health Knowledge, Attitudes, Practice | 12 | 2024 | 989 | 2.670 |
Why?
|
| Puerto Rico | 32 | 2025 | 1413 | 2.670 |
Why?
|
| Parents | 5 | 2024 | 370 | 1.880 |
Why?
|
| Anus Neoplasms | 5 | 2017 | 44 | 1.810 |
Why?
|
| HIV Infections | 15 | 2023 | 2586 | 1.800 |
Why?
|
| Substance Abuse, Intravenous | 5 | 2023 | 129 | 1.760 |
Why?
|
| Patient Acceptance of Health Care | 6 | 2024 | 497 | 1.320 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2017 | 226 | 1.280 |
Why?
|
| Sexual Behavior | 6 | 2017 | 638 | 1.100 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2014 | 174 | 1.090 |
Why?
|
| Colorectal Neoplasms | 2 | 2025 | 512 | 1.080 |
Why?
|
| Heroin Dependence | 4 | 2011 | 23 | 1.050 |
Why?
|
| Adult | 32 | 2025 | 13872 | 1.050 |
Why?
|
| Vaccination | 3 | 2024 | 355 | 1.020 |
Why?
|
| Young Adult | 20 | 2017 | 5080 | 0.980 |
Why?
|
| Male | 35 | 2025 | 23409 | 0.950 |
Why?
|
| Hepatitis C | 2 | 2023 | 139 | 0.910 |
Why?
|
| Middle Aged | 26 | 2025 | 12222 | 0.900 |
Why?
|
| Humans | 44 | 2025 | 43102 | 0.880 |
Why?
|
| Adolescent | 18 | 2024 | 6081 | 0.880 |
Why?
|
| Cyclonic Storms | 1 | 2025 | 80 | 0.820 |
Why?
|
| Intention | 1 | 2024 | 108 | 0.820 |
Why?
|
| Vegetables | 2 | 2014 | 147 | 0.780 |
Why?
|
| Drug Users | 1 | 2023 | 52 | 0.760 |
Why?
|
| Fruit | 2 | 2014 | 178 | 0.750 |
Why?
|
| Female | 24 | 2025 | 24698 | 0.720 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2017 | 367 | 0.700 |
Why?
|
| Homosexuality, Male | 3 | 2017 | 486 | 0.660 |
Why?
|
| Risk Factors | 11 | 2023 | 3994 | 0.650 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 1723 | 0.640 |
Why?
|
| Mass Screening | 3 | 2022 | 541 | 0.630 |
Why?
|
| Alphapapillomavirus | 3 | 2014 | 31 | 0.620 |
Why?
|
| Stress, Psychological | 1 | 2025 | 661 | 0.570 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 3156 | 0.570 |
Why?
|
| Neoplasms | 3 | 2016 | 1377 | 0.570 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 449 | 0.560 |
Why?
|
| Prevalence | 7 | 2023 | 1612 | 0.520 |
Why?
|
| Sex | 1 | 2016 | 4 | 0.510 |
Why?
|
| Risk-Taking | 5 | 2023 | 457 | 0.490 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 64 | 0.490 |
Why?
|
| Communication | 2 | 2016 | 210 | 0.470 |
Why?
|
| Penile Diseases | 1 | 2015 | 6 | 0.470 |
Why?
|
| Community-Institutional Relations | 1 | 2017 | 219 | 0.460 |
Why?
|
| Schools | 3 | 2021 | 283 | 0.450 |
Why?
|
| Harm Reduction | 2 | 2011 | 27 | 0.430 |
Why?
|
| Consumer Health Information | 1 | 2014 | 24 | 0.430 |
Why?
|
| Papillomaviridae | 1 | 2015 | 142 | 0.430 |
Why?
|
| Mouth Diseases | 1 | 2014 | 5 | 0.420 |
Why?
|
| Information Seeking Behavior | 1 | 2014 | 28 | 0.420 |
Why?
|
| Gastroenterology | 1 | 2013 | 8 | 0.420 |
Why?
|
| Anal Canal | 1 | 2014 | 32 | 0.410 |
Why?
|
| Health Personnel | 1 | 2016 | 277 | 0.410 |
Why?
|
| Medical Oncology | 1 | 2013 | 50 | 0.400 |
Why?
|
| Focus Groups | 3 | 2025 | 423 | 0.400 |
Why?
|
| Socioeconomic Factors | 7 | 2016 | 1234 | 0.400 |
Why?
|
| Incidence | 6 | 2017 | 1078 | 0.400 |
Why?
|
| Emigrants and Immigrants | 1 | 2015 | 158 | 0.390 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 148 | 0.390 |
Why?
|
| Syphilis | 1 | 2013 | 24 | 0.390 |
Why?
|
| Penile Neoplasms | 1 | 2012 | 12 | 0.390 |
Why?
|
| Education, Medical | 1 | 2013 | 118 | 0.370 |
Why?
|
| Attitude to Health | 1 | 2015 | 338 | 0.370 |
Why?
|
| Unsafe Sex | 2 | 2012 | 162 | 0.360 |
Why?
|
| Heroin | 1 | 2011 | 18 | 0.360 |
Why?
|
| Sex Factors | 3 | 2024 | 1028 | 0.350 |
Why?
|
| Aged | 9 | 2025 | 8214 | 0.350 |
Why?
|
| Seroepidemiologic Studies | 3 | 2023 | 74 | 0.330 |
Why?
|
| Child | 4 | 2021 | 3443 | 0.330 |
Why?
|
| Promethazine | 1 | 2010 | 4 | 0.320 |
Why?
|
| Health Status Disparities | 1 | 2017 | 719 | 0.320 |
Why?
|
| Self Medication | 1 | 2010 | 13 | 0.320 |
Why?
|
| Feeding Behavior | 1 | 2013 | 469 | 0.310 |
Why?
|
| Hepatitis C, Chronic | 1 | 2010 | 44 | 0.310 |
Why?
|
| Time Factors | 5 | 2017 | 1857 | 0.310 |
Why?
|
| Health Behavior | 1 | 2013 | 575 | 0.300 |
Why?
|
| Age Factors | 4 | 2017 | 1154 | 0.300 |
Why?
|
| Sexual Partners | 4 | 2017 | 326 | 0.300 |
Why?
|
| United States | 6 | 2021 | 5205 | 0.290 |
Why?
|
| Genotype | 4 | 2015 | 800 | 0.280 |
Why?
|
| Diet | 1 | 2014 | 826 | 0.280 |
Why?
|
| Emigration and Immigration | 1 | 2008 | 85 | 0.280 |
Why?
|
| Age Distribution | 4 | 2014 | 249 | 0.270 |
Why?
|
| Vietnam | 3 | 2011 | 62 | 0.250 |
Why?
|
| Health Services Accessibility | 2 | 2025 | 706 | 0.220 |
Why?
|
| Health Promotion | 1 | 2010 | 704 | 0.210 |
Why?
|
| Capacity Building | 2 | 2017 | 99 | 0.210 |
Why?
|
| Comorbidity | 2 | 2017 | 737 | 0.200 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 830 | 0.200 |
Why?
|
| Registries | 3 | 2014 | 437 | 0.200 |
Why?
|
| Hepacivirus | 1 | 2023 | 74 | 0.190 |
Why?
|
| Smoking | 3 | 2014 | 1024 | 0.180 |
Why?
|
| Qualitative Research | 1 | 2025 | 574 | 0.180 |
Why?
|
| Cost of Illness | 2 | 2014 | 98 | 0.180 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 749 | 0.180 |
Why?
|
| Sex Distribution | 3 | 2014 | 224 | 0.180 |
Why?
|
| Colonoscopy | 1 | 2022 | 122 | 0.170 |
Why?
|
| Internet | 1 | 2021 | 236 | 0.150 |
Why?
|
| Poisson Distribution | 1 | 2017 | 44 | 0.130 |
Why?
|
| Sexual Abstinence | 1 | 2016 | 8 | 0.130 |
Why?
|
| Sex Education | 1 | 2016 | 36 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 223 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2017 | 233 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 235 | 0.120 |
Why?
|
| Dominican Republic | 1 | 2015 | 20 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 269 | 0.120 |
Why?
|
| Biomedical Research | 2 | 2011 | 502 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2017 | 246 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2017 | 863 | 0.110 |
Why?
|
| HIV Seroprevalence | 1 | 2014 | 11 | 0.110 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 25 | 0.110 |
Why?
|
| Warts | 1 | 2013 | 5 | 0.100 |
Why?
|
| Human papillomavirus 16 | 1 | 2014 | 37 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 35 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 56 | 0.100 |
Why?
|
| Survival Rate | 1 | 2014 | 355 | 0.100 |
Why?
|
| Guideline Adherence | 1 | 2013 | 98 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2014 | 368 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 238 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2013 | 162 | 0.100 |
Why?
|
| Linear Models | 1 | 2014 | 317 | 0.100 |
Why?
|
| Morbidity | 1 | 2013 | 97 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2013 | 102 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 374 | 0.100 |
Why?
|
| Health Facilities | 1 | 2013 | 32 | 0.100 |
Why?
|
| Data Collection | 1 | 2013 | 210 | 0.100 |
Why?
|
| Health Surveys | 1 | 2014 | 405 | 0.100 |
Why?
|
| Epidemiologic Methods | 1 | 2012 | 56 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 186 | 0.090 |
Why?
|
| Culture | 1 | 2013 | 172 | 0.090 |
Why?
|
| Risk | 1 | 2013 | 287 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2014 | 452 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 1 | 2012 | 68 | 0.090 |
Why?
|
| Logistic Models | 1 | 2015 | 1009 | 0.090 |
Why?
|
| Trust | 1 | 2014 | 167 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2013 | 146 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 67 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 92 | 0.090 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 166 | 0.090 |
Why?
|
| Age of Onset | 1 | 2011 | 114 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 291 | 0.090 |
Why?
|
| Physicians | 1 | 2013 | 188 | 0.090 |
Why?
|
| Students, Medical | 1 | 2013 | 158 | 0.090 |
Why?
|
| Prognosis | 1 | 2014 | 861 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1067 | 0.090 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 67 | 0.080 |
Why?
|
| Patient Selection | 1 | 2012 | 205 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 259 | 0.080 |
Why?
|
| Health Status | 1 | 2014 | 442 | 0.080 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 160 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2012 | 760 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 2853 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 616 | 0.070 |
Why?
|
| Disease Progression | 1 | 2011 | 667 | 0.070 |
Why?
|
| Minority Groups | 1 | 2012 | 690 | 0.060 |
Why?
|
| Depression | 1 | 2014 | 863 | 0.060 |
Why?
|
| Acculturation | 1 | 2008 | 205 | 0.060 |
Why?
|
| Mexican Americans | 1 | 2008 | 226 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2010 | 1600 | 0.060 |
Why?
|
| Body Piercing | 1 | 2005 | 2 | 0.060 |
Why?
|
| Tattooing | 1 | 2005 | 7 | 0.060 |
Why?
|
| Obesity | 1 | 2013 | 1151 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2005 | 31 | 0.060 |
Why?
|
| HIV-1 | 1 | 2011 | 755 | 0.060 |
Why?
|
| Health Occupations | 1 | 2005 | 19 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 102 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2008 | 1759 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 1092 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2012 | 120 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 245 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 288 | 0.020 |
Why?
|